Hedge Fund - MIC Capital Partners
Recursion Pharmaceuticals Inc. (RXRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $39,444,095 | 8.94% | 9,644,032 | $4.95 |
| 2 | 2025 - Q3 (2025-09-30) | $47,062,881 | 9.41% | 9,644,032 | $5.25 |
| 3 | 2025 - Q2 (2025-06-30) | $48,798,807 | 9.58% | 9,644,032 | $4.91 |
| 4 | 2025 - Q1 (2025-03-31) | $51,016,935 | 10.39% | 9,644,032 | $7.29 |
| 5 | 2024 - Q4 (2024-12-31) | $65,193,663 | 9.23% | 9,644,033 | $6.72 |
| 6 | 2024 - Q3 (2024-09-30) | $55,697,086 | 7.73% | 8,451,758 | $7.17 |
| 7 | 2024 - Q2 (2024-06-30) | $63,388,186 | 13.77% | 8,451,758 | $8.72 |
| 8 | 2024 - Q1 (2024-03-31) | $84,264,027 | 16% | 8,451,758 | $11.14 |
| 9 | 2023 - Q4 (2023-12-31) | $83,334,334 | 16.16% | 8,451,758 | $7.13 |
| 10 | 2023 - Q3 (2023-09-30) | $64,655,952 | 14.73% | 8,451,758 | $9.98 |
| 11 | 2023 - Q2 (2023-06-30) | $63,134,635 | 12.84% | 8,451,758 | $7.00 |
| 12 | 2023 - Q1 (2023-03-31) | $56,373,229 | 10.75% | 8,451,758 | $7.93 |
| 13 | 2022 - Q4 (2022-12-31) | $65,163,057 | 12.86% | 8,451,758 | $9.81 |
| 14 | 2022 - Q3 (2022-09-30) | $89,927,000 | 16.2% | 8,451,758 | $10.13 |
| 15 | 2022 - Q2 (2022-06-30) | $68,798,000 | 13.45% | 8,451,758 | $6.69 |
| 16 | 2022 - Q1 (2022-03-31) | $9,944,000 | 1.93% | 1,388,889 | $10.63 |
| 17 | 2021 - Q4 (2021-12-31) | $23,792,000 | 4.55% | 1,388,889 | $18.82 |
| 18 | 2021 - Q3 (2021-09-30) | $31,958,000 | 5.87% | 1,388,889 | $28.34 |
| 19 | 2021 - Q2 (2021-06-30) | $50,694,446,000 | 9.21% | 1,388,889 | $29.38 |
The displayed share prices are average quarterly stock market prices.